CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Won Gil Chung, Hong Joo Kim, Young Gil Choe, Hyo Sun Seok, Chang Wook Chon, Yong Kyun Cho, Byung Ik Kim, Young Yool Koh
Clin Mol Hepatol. 2012;18(2):195-202.   Published online 2012 June 26    DOI: https://doi.org/10.3350/cmh.2012.18.2.195

Excel Download

Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection
Clinical and Molecular Hepatology. 2012;18(2):195   Crossref logo
Link1 Link2 Link3

Current Therapy of Chronic Hepatitis C Virus in Treatment-Naive Patients
Viral Hepatitis: Chronic Hepatitis C. 2019;65-95   Crossref logo
Link1

Entecavir for the treatment of chronic hepatitis B virus infection
Clinical Therapeutics. 2006;28(2):184-203   Crossref logo
Link1 Link2

Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management
Current Hepatitis Reports. 2012;11(2):90-94   Crossref logo
Link1 Link2 Link3

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
Drug Design, Development and Therapy. 2013;13   Crossref logo
Link1

Su1414 A Randomized Controlled Trial to Compare the Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Naïve Chronic Hepatitis B Patients
Gastroenterology. 2015;148(4):S-502   Crossref logo
Link1 Link2

529 Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleoside-naive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B
Journal of Hepatology. 2005;42:192   Crossref logo
Link1 Link2

Corrections: Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response
Hepatology. 2011;54(6):2281-2282   Crossref logo
Link1

509 The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleo side-naive, HBeAg(+) and HBeAg(−) patients with chronic hepatitis B
Journal of Hepatology. 2005;42:184   Crossref logo
Link1 Link2

Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B
Liver International. 2009;30(6):834-840   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.